Sana Biotechnology, Inc. (SANA) Stock Rating

Sana Biotechnology Inc is a biotechnology company that develops engineered cells as medicines and therapies. Its cell engineering programs span several therapeutic areas with unmet needs, including oncology, diabetes, B-cell-mediated autoimmune disease, and central nervous system (CNS) disorders, with a candidate pipeline that includes SC291, SC262, UP421, and others.